Sponsor Pipeline

Shenzhen Wingor Biotechnology Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
1
Disease Areas
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-07-30 NCT07084012
A Phase IIa Clinical Trial to Evaluate the Efficacy and Safety of Intravenous Infusion of…		 date change Primary completion pushed: 2026-03-05 -> 2027-05-31
2026-07-30 NCT07084012
A Phase IIa Clinical Trial to Evaluate the Efficacy and Safety of Intravenous Infusion of…		 date change Completion pushed: 2026-12-05 -> 2028-12-30
Active Trials by Phase
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07084012 A Phase IIa Clinical Trial to Evaluate the Efficacy and Safety of Intravenous Infusion of… Acute Ischemic Stroke AIS Recruiting
Disease Areas
Stroke (1)
Get alerts when Shenzhen Wingor Biotechnology Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free